ALLR Allarity Therapeutics, Inc.: institutional ownership and insider trading
21 funds reported holding $1.92M of Allarity Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $426K, with 8 new positions and 2 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
ALLR revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0, net income −$3.41M
- Quarter ended Mar 31, 2026: revenue $25.0K, net income −$2.75M
- Quarter ended Dec 31, 2025: revenue n/a, net income −$3.37M
- Quarter ended Sep 30, 2025: revenue n/a, net income −$2.81M
Famous investors holding ALLR
- Renaissance Technologies (Renaissance Technologies): $428K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $118K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $35.5K, 0.0% of the portfolio
Largest institutional holders of ALLR
- RENAISSANCE TECHNOLOGIES LLC — $428K
- VANGUARD GROUP INC — $266K
- VANGUARD CAPITAL MANAGEMENT LLC — $222K
- GEODE CAPITAL MANAGEMENT, LLC — $200K
- STATE STREET CORP (STT, STT-PG) — $178K
- Militia Capital Management LLC — $128K
- CITADEL ADVISORS LLC — $118K
- VANGUARD FIDUCIARY TRUST CO — $96.6K
- NORTHERN TRUST CORP (NTRS, NTRSO) — $47.1K
- HRT FINANCIAL LP — $47.0K